Lupin settles with Forest over US memantine litigation
This article was originally published in Scrip
Executive Summary
Lupin has settled all ongoing litigation with Forest Laboratories concerning memantine tablets, Lupin's generic version of Forest's Alzheimer's disease treatment, Namenda tablets.